Abstract: Studies have shown a relationship between vitamin D and psoriasis. We compared serum levels of vitamin D of 20 psoriasis patients and 20 controls. The median vitamin D level was 22.80 ± 4.60 ng/ml; the median in the cases was 23.55 ± 7.6 ng/ml, and in controls 22.35 ± 3.10 ng/ml (p = 0.73). Only 2 cases and 4 controls had suffi cient levels of vitamin D, although without statistical signifi cance between the groups (p = 0.608). Levels were lower in women with psoriasis compared with those in male patients (20.85 ± 6.70 x 25.35 ± 2.90 ng/ml, p = 0.03), a fi nding that was not observed among controls. Psoriasis is a systemic, infl ammatory, chronic autoimmune disease that affects between 1 and 3 % of the global population.
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Faculdade Evangélica do Paraná (FEPAR) -Curitiba (PR), Brazil. Psoriasis is a systemic, infl ammatory, chronic autoimmune disease that affects between 1 and 3 % of the global population. 1 Its pathogenesis is not totally clear, but it is a known fact that there is activation of sectors of innate and adaptive immune response. 2, 3 Vitamina D (25-hydroxyvitamin D) is a hormone whose synthesis is stimulated by cutaneous exposure to ultraviolet B radiation. 4 It acts on calcium homeostasis, on bone metabolism and has immune regulating functions that have been recently recognized. 5 Some studies have demonstrated a relationship between vitamin D defi ciency and psoriasis. 6, 7 This study compares serum levels of vitamin D of 20 adults with active psoriasis and 20 patients seen at the outpatient dermatology clinic of the Teaching Hospital of the Evangelical College of Curitiba, in Curitiba -PR, between July and September of 2013. Those patients who were using medications that interfere on vitamin D levels, were undergoing phototherapy, had infl ammatory or disabsortive bowel disease, liver disease, chronic kidney insuffi ciency and other autoimmune disorders were excluded.
The analysis of vitamin D serum levels was performed by chemiluminescent immuneassay and values <20 ng/ml were considered defi ciency, from 20 to <30 ng/ml insuffi ciency and ≥30 ng/ml suffi ciency.
Statistical data were evaluated by the following tests: Fisher's Exact, Student's t, Mann-Whitney, Spearman and ANCOVA; the values were considered signifi cant when P< 0.05.
The group of cases was composed of 12 women and 8 men, aged between 19 and 76 years (mean age 46.40±14.90 years) and median disease duration The control group was composed of 20 patients (14 women and 6 men), aged between 19 and 84 years (mean 47.80±18.86 years). Table 1 shows demographic data and serum levels of 25-hydroxyvitamin D in the patients. Distributions by gender, age and phototype were not significantly different. Only 2 cases and 4 controls presented suffi cient levels of vitamin D. Including all of the participants in the study, the median vitamin D level was 22.80±4.60 and it was lower in those that were exposed to sunlight for less than 30 minutes per day (P =0.04).
We did not fi nd signifi cant differences in vitamin D levels between patients with psoriasis and controls (P = 0.735). Wilson et al carried out a study using the National Health and Nutrition Examination Survey (NHANES) information base and found, in a group of 5841 individuals, 148 patients with psoriasis that were compared to the 5693 individuals without the disease. The investigators did not report differences in serum levels or defi ciency of vitamin D between the patients with and without psoriasis, with prevalence of defi ciency in 33% and 34.9% of the participants with and without the disease, respectively. 8 Orgaz-Molina et al, however, observed lower serum levels of vitamin D in patients with psoriasis when compared with controls; 25.6% of the individuals with psoriasis and 93% dos controls presented defi ciency of this hormone. 7 In the study by Gisondi et al, the participants with psoriasis presented a risk 2.5 times greater of having 25-hydroxyvitamin D defi ciency than those without the disease. 9 Ricceri et al found a prevalence of 68% of vitamin D defi ciency and 97% of insuffi ciency in the patients with psoriasis studied, while the percentages found in the control group were 10% of defi ciency and approximately 53% of insufficiency of this hormone. Our study also found association between serum levels of vitamin D and gender. Vitamin D levels were lower in women with psoriasis in comparison with men (P =0.03), a fact not observed among controls (P =0.62). The median daily sun exposure time was also shorter in women with psoriasis compared with men with psoriasis (P =0.049), which also did not occur with controls (P =0.99). This association may be due to the relatively small number of cases or some uncontroled variable, like wearing cosmetics with sunscreen effect, more common among women. 7 In spite of this, the covariance analysis of the group of psoriasis patients, controled by daily sun exposure levels, showed that the female gender was associated with lower levels of vitamin D independently from time of sun exposure (P=0.01). Table 2 illustrates the characteristics of patients with psoriasis according to gender. The studies conducted by Orgaz-Molina et al and Ricceri et al, which also evaluated these variables, did not fi nd signifi cant differences between vitamin D levels and gender. 7, 10 Vitamin D insuffi ciency was very frequent in this population, although no signifi cant differences were found in vitamin D serum levels between patients with psoriasis and other dermatology patients. 
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